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Integrins are heterodimeric cell adhesion molecules that play an essential role in 
hemostasis, thrombosis, cell migration, and can transmit bidirectional signals. The inside-out 
activating signal triggers integrin conformational change, leading to high affinity for 
extracellular ligands. Binding of extracellular matrix ligands to integrins results in outside-in 
signaling that leads to formation of focal adhesion (FA) complex at the integrin cytoplasmic tails 
and activation of downstream signal pathways.  
Transmembrane/cytoplasmic domains are hypothesized to associate in resting integrins, 
whereas ligand binding and intracellular activating signals induce transmembrane domain 
separation. However, how this conformational change affects integrin outside-in signaling and 
whether the α subunit cytoplasmic domain is important for this signaling remain elusive. Using 
Chinese Hamster Ovary (CHO) cells that stably expressed different integrin αIIbβ3 constructs, we 
discovered that an αIIb cytoplasmic domain truncation led to integrin activation but not defective 
outside-in signaling. In addition, preventing transmembrane domain separation abolished both 
inside-out and outside-in signaling. Our research revealed that transmembrane domain separation 
is a downstream conformational change after the cytoplasmic domain dissociation in inside-out 
activation and indispensable for ligand-induced outside-in signaling.  
It has been proposed that integrins adopt a bent, low affinity conformation under 
physiological conditions and can switch to an extended conformation through a “switchblade”-
like conformational change. It is extremely important to verify if the model universally applies to 
all integrin families. Due to the highly divergent cytoplasmic domain, β8 integrin is unlikely to 
adopt a general mechanism for affinity regulation. Therefore the β8 integrin may uniquely 
vii 
assume an extended, high affinity conformation under physiological conditions. We discovered 
that β8 indeed showed high binding to vitronectin under physiological conditions. Further studies 
identified that the I-EGF domains on the β8 integrin extracellular lower leg are critical for this 
high affinity conformation. We also pinpointed a critical role of the β8 integrin EGF domain 1 
and 2 in this high affinity conformation. Mutating either one of the cysteine pair at the β3 EGF1 
domain C-terminus resulted in high affinity conformation, probably due to disruption of the 
EGF1-EGF2 interface. Our study also showed that the β8 ectodomain lower stalk does not 
negatively affect outside-in signaling.
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CHAPTER ONE: GENERAL INTRODUCTION1 
Integrin Biology 
Integrins are single transmembrane (TM) α-β heterodimeric cell adhesion receptors with 
each subunit comprised of a large extracellular domain, a single TM helix, and a short 
cytoplasmic domain [1-4]. In vertebrates, different combinations of eighteen α and eight β 
subunits constitute a large family of twenty-four members, which bind to different tissue- and 
organ-specific ligands[2-4]. Integrins can transmit bidirectional signals across the plasma 
membrane. Studies have shown that in the resting state, the integrin ectodomain adopts a bent 
conformation that is stabilized by specific α/β interfaces within the extracellular, TM, and 
cytoplasmic domains. Integrins can be activated through an “inside-out” signaling pathway that 
results in an extended conformation with high affinity for ligands [5]. Upon interacting with 
multivalent extracellular ligands, integrins can transmit signals inward, i.e. outside-in signaling, 
which influence biological processes such as cell mobility, proliferation, and differentiation [6].  
Integrin conformational change plays a critical role in integrin bidirectional signaling. 
Recently, a large number of studies have together established that the bent conformation of the 
integrin extracellular domain represents the physiological low-affinity resting state for ligand as 
unveiled by X-ray crystallography and electron microscopy [7-10]. This state is believed to be 
critical for normal integrin function. Priming and ligand binding induce a large scale 
conformational rearrangement in which the integrin extends with a “switchblade-like” motion, 
and the extended conformation with two separated legs represents a high affinity state 
(Fig.1)[8,11]. This conformational change is particularly important for many integrins, such as β2 
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On the cell surface, integrins normally adopt the low affinity state. Cell surface receptors 
such as human thrombin receptor Protease-Activated Receptor 1 (PAR1) transmit activating 
signals from extracellular agonists cross the cell membrane, rapidly triggering integrin 
conformational change to the high affinity state [14,15]. The integrin TM/cytoplasmic domains 
are important in regulating integrin affinity and mediating downstream signal transduction. For 
most integrins, association of the TM/cytoplasmic domains between  and  subunits is critical 
for maintaining the integrin in the low-affinity state. Intracellular signals that impinge on the 
cytoplasmic domain destabilize  association and result in integrin activation [13,16-23]. 
Recent research has revealed the structures of both the associated and isolated monomers of the 
TM/cytoplasmic domains and greatly advanced our understanding of TM activation [24-30].  In 
the resting state, ridge-in-groove packing of the TM domain and the GFFKR motif in the  
subunit cytoplasmic domain are important for  association, whereas binding of intracellular 
molecules such as talin [31] dissociates the  TM/cytoplasmic domains and leads to integrin 
activation (Fig. 2).  
Transmembrane domain and integrin signaling 
It is well known that the association of the TM and cytoplasmic domains between the α and 
the β subunits is essential for integrin in the low affinity state whereas disrupting this interaction 
resulted in integrin activation [18,32-34].  Specific interfaces on the integrin  and  subunit TM 
domains have been defined by several mutagenesis studies and disruption of these interactions 
results in activation. A newly developed method combining disulfide scanning with Rosetta 
computational modeling has been used to solve the structure of the integrin IIb3 TM and 
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and Val-990, and then Gly-991 of GFFKR is a turn which makes Phe-992 and Phe-993 sit in the 
interface of IIb and 3 at the membrane/cytoplasm interface. In the structure, Arg-995 is close to 
both Asp-723 and Glu-726, consistent with electrostatic interaction. However, there are a variety 
of different conformations of the side chains of Arg-995 and Asp-723, indicating that this salt 
bridge is not absolutely necessary for the association. The 3 residue Lys-716 has the most 
important role in the IIb interface. The aliphatic portion of the Lys-716 side chain is in the 
interface with the IIb GFFKR motif and remarkably, the Lys-716 ɛ-amino group hydrogen 
bonds to the IIb backbone. Mutations of Lys-716 to any other residues activate integrins for 
ligand binding [27]. This Lys-716 is structurally critical for / association as well as for the 
tilting of the dissociated  TM and cytoplasmic helix in the plasma membrane. 
 Rearrangements of the integrin TM and cytoplasmic domains are necessary for integrin 
activation. Several different models of the integrin TM domain conformational changes have 
been proposed, including separation, hinging and piston-like motions [38-40]. Accumulated data 
tend to support separation of the  and  TM/cytoplasmic domains in integrin activation. First, 
ectodomain-TM domain linkers are flexible, indicating that the large-scale movement (like 
separation) of the TM domain is necessary to trigger conformational change of the ectodomain 
[9]. FRET studies on L2 and M2 suggested that unclasping of the TM and cytoplasmic 
domains is required for integrin signal transduction [41]. Mutational and disulfide scanning 
studies also confirmed TM domain separation but not hinging or piston-like motions as the 
mechanism of TM signaling [42].  
The NMR structures of the isolated IIb and 3 TM/cytoplasmic domain fragments were 
resolved in phospholipid bicelle [24,25]. These structures are believed to represent the 
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physiologically active state in which the TM and cytoplasmic domains are in the dissociated 
monomeric conformation. The dissociated 3 TM domain solved by NMR appeared to be 
significantly longer than that in the Disulfide/Rosetta complex structure, suggesting that after 
dissociating from the IIb helix, the 3 helix is tilted due to inserting of 5-6 additional 
hydrophobic residues to the hydrophobic lipid environment. The tilting of the 3 helix may be 
important for integrin activation and signaling [13].  
The inside-out activation of integrins involves binding of intracellular proteins to integrin 
cytoplasmic domains, leading to switchblade-like conformational change of integrin extracellular 
domains. This process may be coupled with following conformational changes of the integrin 
TM and cytoplasmic domains: 1) separation of two TM and cytoplasmic helices; 2) following 
separation,  subunit helix maintains the similar structure, whereas the  subunit helix is tilted by 
inserting 5-6 additional residues into the hydrophobic lipid membrane core [13]. Binding of 
integrin TM and cytoplasmic domains to intracellular proteins that induces separation of the α 
and β legs will lead to integrin extension and swing-out of the hybrid domain, resulting in high 
affinity for ligands. 
TM separation has also been reported to be required for outside-in signaling [13,43]. 
Exposure to extracellular matrix (ECM) ligands induces integrin conformational change and 
clustering, which in turn increases ligand binding valency or avidity. Clustered integrins not only 
provide stable connections to ECM but also transfer extracellular information into corresponding 
intracellular reactions by recruiting effectors to integrin cytoplasmic tail. This outside-in 
signaling of integrin regulates cell shape, migration, growth, and survival. It has been shown that 
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both lateral association (i.e., clustering) of integrin heterodimers and the conformational change 
of the receptors are required for conveying outside-in signals [11,43-45].  
Inside-out signaling of integrin 
Signaling intermediates linking agonist receptors to integrin activation 
Binding of integrin ligands can be induced by soluble extracellular agonists such as 
adenosine diphosphate and thrombin. G protein coupled receptors including thrombin receptor 
PAR1 are involved in agonist-induced integrin activation [14,46,47]. Though the up stream 
pathway may vary, Rap1, a subfamily of small GTPase has emerged as a common downstream 
activator in the inside-out integrin activating signaling pathway [48-50]. Rap1 probably functions 
downstream of Protein Kinase C (PKC), an important effector in GPCR mediated signal pathway 
[51]. Rap1 can form complex with the integrin activator talin through its binding partner Rap1-
GTP-interacting adaptor molecule and thus facilitate targeting of talin to β integrin cytoplasmic 
tail [51]. In this scenario, RIAM is a critical effector in recruiting talin to plasma membrane as 
knocking down the adaptor blocked PAR mediated integrin αIIbβ3 activation [52]. Furthermore, 
Lee et.al confirmed that only the N terminal talin-interacting domain and Rap1 membrane 
targeting sequence of RIAM are required for talin recruitment and integrin activation [53].  
Talin and integrin activation 
Talin is a 270 KD protein which is composed of a 50 KD N-terminal globular head 
domain and a 220 KD C-terminal rod domain. The talin head domain [54] contains three FERM 
(protein 4.1,ezrin, radixin, moesin) subdomains: F1, F2 and F3, and a non-homologous F0 
domain. The PTB (Phosphotyrosine Binding) domain is located in the F3 subdomain and binds 
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to the conserved membrane-proximal NPxY motif of β integrin cytoplasmic tail, and binding of 
the F3 domain is sufficient to activate integrins [55]. 
THD has two binding sites in the β integrin cytoplasmic domain. It can bind strongly to 
the NPxY motif and weakly to the membrane proximal part of β3 integrin [31]. Mutations that 
interrupt the strong integrin-talin interaction (NPxY-talin interaction) totally abolished the ability 
of talin to activate integrin whereas disrupting the weak talin-integrin interaction showed little 
effect on talin affinity but reduced integrin activation [31,56]. Talin can also interact with 
negatively-charged inner membrane phospholipid head group through its F2 and F3 domain. 
This interaction is important in precise talin-integrin positioning and interrupting the interaction 
resulted in defected integrin activation [31,57]. Binding of talin to β integrin tail may cause TM 
domain separation (Fig.2), leading to integrin activation [5,57,58]. An in-vitro reconstruction of 
integrin activation showed that binding of THD alone is sufficient to trigger integrin global 
extension and activation in lipid nanodiscs [59]. 
The rod domain of talin contains multiple binding sites for actin and vinculin and an 
autoinhibitory binding site to its own integrin activating THD [60-62]. Interaction of talin with 
phosphatidylinositol-4,5-biphosphate can release this autoinhibition [63]. The C-terminal rod of 
talin also has essential role in integrin signaling. Over expression of THD cannot restore integrin 
clustering and focal adhesion formation in talin depleted cells and a more recent research 
implicated a potential role of talin rod domain in cell proliferation regulation, indicating the 





Kindlin, a co-activator of integrin 
Another integrin binding protein kindlin also plays a critical role in integrin activation 
[58,66]. The kindlin family consists three members: kindlin1, kindlin2 and kindlin3. Kindlins are 
well conserved in animals and defects in family members can cause serious diseases. It has been 
shown that loss of functional kindlin1 causes Kindler’s Syndrome [67,68], genetic ablation of 
kindlin2 or kindlin3 is embryonic lethal [69,70], and loss of kindlin3 leads to a subset of 
leukocyte adhesion deficiency III [71-73]. Kindlins have three C-terminal FERM domains, 
similar to talin, but the F2 domain is split by an inserted Pleckstrin Homology domain. While 
talin strongly binds to the membrane proximal region of the β integrin cytoplasmic domain, 
kindlin F3 domain interacts with the membrane distal NxxY motif [70,74]. Unlike THD, kindlin 
itself is not activating as overexpression of kindlin3 in the CHO cell model failed to activate 
integrin αIIbβ3 and transient expression of kindlin1 and kindlin2 in CHO cells inhibited β1 and β3 
integrin activation [74]. However, when co-expressed with THD, kindlin1 and kindlin2 further 
enhanced αIIbβ3 activation, indicating that kindlin synergizes with THD to exert activating 
function on integrin [74,75]. Recent study showed that talin binding induces the extended, 
intermediate affinity state of integrin, leading to cell rolling, whereas binding of both talin and 
kindlin3 induces integrin extended, high affinity state with an open headpiece, leading to 
neutrophil arrest [76]. Interestingly, kindlin1 and kindlin2 are inhibitory for β1 integrin even 
when THD is co-expressed [74], implying that integrin co-activating functions of different 
kindlins are cell-type and integrin-specific [74,75,77].    
Integrin outside-in signaling across the plasma membrane  
In physiological conditions, only a fraction of integrins on the cell surface may adopt an 
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Akt activity. Src also activates Akt and can furthermore promote cell proliferation through Ras-
Erk pathway. 
 
Recruitment of FAK and SFK: 
FAK recruitment to the integrin cytoplasmic tail is an early event in outside-in signaling 
[78,79]. This non-receptor tyrosine kinase is highly conserved and FAK knock-out is embryonic 
lethal in mice [80]. FAK consists of an N-terminal FERM domain, which functions as activation 
switch and adaptor, a central catalytic domain, a proline-rich region and a C-terminal FAK 
Adhesion Targeting domain. In the resting state, the FERM domain interacts with its own 
catalytic domain and therefore blocks accessibility of FAK substrates [81-83]. Early evidence 
indicated that interaction between FAK FERM domain and β integrin tail releases this 
autoinhibition, causing FAK autophosphorylation and activation [84]. Displacement of the 
FERM domain from its catalytic domain results in autophosphorylation on tyrosine 397, which 
leads to Src activation. Then activated Src further phosphorylates and promotes FAK activity. 
FAK activation is closely associated with focal adhesion formation and cell migration. FAK 
inhibition could result in compromised cell mobility whereas enhanced FAK activity promoted 
cell migration [85]. Fluorescent resonance energy transfer study revealed FAK activation at 
growing focal adhesions but not stable or retracting focal adhesions, indicating important role of 
FAK in oriented cell migration [86]. It is believed that FAK activity is required for efficient focal 
adhesions turnover in cell migration and the kinase can regulate localization and activity of 
several key GTPases including RhoA, cdc42 and Rac-1 [87,88]. 
 Similar to FAK, SFKs are non-receptor tyrosine kinases and play an important role in 
integrin outside-in signaling. SFK contains nine members among which Src, Fyn and Yes are 
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ubiquitously expressed and the rest are expressed in hematopoietic cells. Activity of SFK is 
constrained by a well-characterized autoinhibitory mechanism: a C-terminal phosphorylated 
tyrosine residue binds to its SH2 domain and thus blocks catalytic domain. Upon 
autophosphorylation, FAK tyrosine 397 competes with Src SH2 domain and releases its 
autoinhibition [85,89]. Integrin cytoplasmic tail can also interact directly with and activate SFK. 
Studies showed that certain population of Src constitutively binds to β3 integrin cytoplasmic 
domain and is activated after integrin clustering induced by ECM ligands binding [90]. SFK 
activity is reported to be required for integrin αIIbβ3 mediated outside-in signaling and the 
constitutive integrin-bound Src is important in outside-in signaling initiation [91]. 
Small GTPases in outside-in signaling 
Small GTPases including Rac, cdc42 and RhoA spatiotemporally regulate cytoskeleton 
dynamics during cell spreading and migration. These GTPases become activated upon GTP 
binding and deactivated after GTP hydrolysis. Active Rac is found concentrated at leading edge 
of cell and promotes formation of lamellipodial protrusion [92,93]. During outside-in signaling, 
Rac is activated by Rac activating guanine exchange factor DOCK, which is recruited to the 
integrin cytoplasmic tail by p130CAS and paxillin [94]. Cdc42 is reported to be essential in 
maintaining cell polarity as ablation cdc42 resulted in defected cell polarity in C. elegans and 
hepatocytes [95,96]. RhoA functions opposite to Rac. The protein promotes actin nucleation, 
cell contractility and F-actin filament elongation. RhoA activity is transiently suppressed at 
nascent lamellipodial protrusion through FAK-Src pathway or through Rac [97-99]. RhoA 
activation leads to stabilizing focal adhesion and inhibits cell protrusion. This antagonistic 
function of RhoA as to Rac highlights the importance of proper and accurate spatiotemporal 





TM domain and integrin outside-in signaling 
 It is known that integrin cross-linking and clustering are required for outside-in signaling 
[100-102]. It has also been shown that activating mutations of the TM domains induced FAK 
activation, but this was proposed to be due to integrin clustering, thought to result from 
homomeric TM domain association [103]. Although the TM homo-oligomerization was found in 
micelles and bacterial cell membranes [104-106], it has never been observed in mammalian cell 
membranes using full-length integrins. Disulfide scanning of intact integrin αIIbβ3 showed that 
integrin TM domains do not form homo-oligomers before or after soluble ligand binding or 
during integrin inside-out and outside-in signaling[45]. By contrast, TM domain separation is an 
absolute requirement for integrin activation or inside-out signaling. Mutagenesis study showed 
that cell spreading was defective when separation of integrin αIIbβ3 TM domain was prevented by 
disulfide bond [43]. FAK activation and focal adhesion formation were also defective in cells 
expressing clasped integrin, indicating that TM separation is required in outside-in signaling [43]. 
Similarly, studies of integrin extracellular domains showed that separation of the integrin legs is 
also required for outside-in signaling [44,45]. 
 Outside-in signaling requires recruitment of key components of focal adhesion complex 
to integrin cytoplasmic domain. This process involves robust covalent modification including 
phosphorylation on β integrin cytoplasmic tail and its binding partners as well as exchanging and 
displacing of proteins that have already bound [107]. Previous study showed that tyrosine 
phosphorylation on β integrin membrane proximal NPxY motif decreases talin binding and thus 
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induces talin displacement from integrin cytoplasmic domain by other proteins such as Dok1 
[108]. Catalytic and scaffold proteins including FAK, Src and paxillin are also phosphorylated 
when recruited to cell membrane during outside-in signaling. This active binding exchange 
implies that a disassociated TM domain is required in order to make cytoplasmic domain 
accessible and in a favorable binding state. Moreover, Fyn, FAK and paxillin are shown to 
interact directly with β integrin membrane proximal region which is important for integrin TM 
heterodimeric association required for constraining integrin activity [5,84,109]. Binding of these 
proteins probably disrupts any potential interactions between β and α integrin at this region and 
therefore maintains TM domain separation. Taking together, it is rational to propose that TM 




   
15 
 
CHAPTER TWO: INTEGRIN αIIbβ3 TRANSMEMBRANE DOMAIN 
SEPARATION MEDIATES BI-DIRECTIONAL SIGNALING ACROSS 
THE PLASMA MEMBRANE2 
 
Introduction  
Integrins are single transmembrane (TM) α-β heterodimeric cell adhesion receptors with 
each subunit comprised of a large extracellular domain, a single TM helix, and a short 
cytoplasmic domain [1-4]; integrins can transmit bidirectional signals across the plasma 
membrane. Studies have shown that in the resting state,  the ectodomains adopt a bent 
conformation that is stabilized by specific α/β interfaces that exist in the extracellular, TM, and 
cytoplasmic domains. Integrins can be activated through an “inside-out” signaling pathway that 
results in an extended conformation with high affinity for ligands [5]. Upon interacting with 
multivalent extracellular ligands, integrins can transmit signals inward, i.e. outside-in signaling, 
that influence biological processes such as cell mobility, proliferation, and differentiation [6].  
The integrin TM/cytoplasmic domains regulate integrin affinity and mediate downstream 
signal transduction. Association of the TM/cytoplasmic domains between the  and  subunits is 
critical for maintaining integrins in the low-affinity state. Intracellular signals that impinge on the 
cytoplasmic domain destabilize  association and result in integrin activation [13,16-23]. 
Recent research has revealed the structures of both the associated and isolated monomers of the 
TM/cytoplasmic domains and greatly advanced our understanding of TM activation [24-30].  In 
the resting state, ridge-in-groove packing of the TM domain and the GFFKR motif in the  
subunit cytoplasmic domain are important for  association, whereas binding of intracellular 
                                                            
2Integrin αIIbβ3 transmembrane domain separation mediates bi-directional signaling across the plasma 
membrane. Hu P, Luo BH. PLoS One. 2015 Jan 24;10(1):e0116208.  
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molecules such as talin [31] dissociates the  TM/cytoplasmic domains and leads to integrin 
activation.  
TM separation has also been reported to be required for outside-in signaling [13,43]. 
Previous studies indicated that clasping of the TM domain abolished cell spreading and focal 
adhesion (FA) formation [43]. However, the research left a critical question unanswered: if TM 
domain separation is essential or it is cytoplasmic domain dissociation that actually matters since 
TM clasping can probably cause defects in cytoplasmic domain dissociation. TM separation is 
likely an intermediate conformational change that either couples cytosol activation with 
ectodomain extension/opening in integrin activation or mediates cytoplasmic domain separation 
upon immobilized ligands binding in outside-in signaling. Therefore, TM separation might not 
be truly “essential” in outside-in signaling and can be bypassed by artificially dissociating 
cytoplasmic domains. To reach a comprehensive understanding of integrin transmembrane 
signaling, especially outside-in signaling, it is extremely important to dissect the role of TM 
separation from cytoplasmic domain separation in integrin signaling. Besides the β subunit, the α 
subunit has also been reported to be important for outside-in signaling, especially for paxillin 
signaling [110,111]. It has been shown that binding of paxillin to the α4 and α9 integrin 
cytoplasmic tails negatively affects cell spreading but can promote cell migration [110,112]. 
However, since paxillin also binds to β3 integrin in vitro [113] and no direct interactions between 
paxillin and β3 integrin partners (αv and αIIb) have been reported, we speculated that the α 
cytoplasmic tail might be dispensable for outside-in signaling mediated by the β3 integrin 
families. Kinase activation has been regarded as an essential step in integrin outside-in signaling; 
it is involved with a complex network and affects not only mechano-related cellular events such 
as spreading and migration but also cell survival and proliferation [114]. Many kinases have 
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been reported to be important for outside-in signaling including focal adhesion kinase (FAK) 
[78], Src family kinase [90], and the PI3K/Akt pathway [115,116]. However, studies using FAK 
inhibitor or an unactivatable Src kinase mutant achieved nearly normal cell spreading, a 
signature of normal outside-in signaling [117,118], suggesting that spreading does not require 
high enzymatic activity of the kinases. This conflicting evidence makes it difficult to understand 
how the ligand binding induced integrin TM/cytoplasmic domain conformational changeaffects 
the signaling cascade.  
In this paper, we chose to use CHO cells which are widely used in integrin signaling 
study [13,43,51,74,90] to establish cell lines that stably express wild type and mutant αIIbβ3 to 
study integrin signaling. Although the cell line does not express surface receptors that respond to 
extracellular stimuli and activate integrin through inside-out signaling pathway, in our study, the 
upstream inside-out signaling pathway was bypassed by αIIb subunit truncation and thus absence 
of platelet surface receptors unlikely affected our study in integrin bidirectional signaling. Lipid 
composition has been implicated to be important in integrin activation and clustering[119]. 
However, currently there is no evidence suggesting that the lipid composition differences 
between platelet and CHO cell can significantly alter the integrin signaling. This makes the cell 
line the most suitable model for integrin signaling research.  
Our results showed that TM domain dissociation is a downstream conformational change 
following cytoplasmic dissociation in inside-out activation and a prerequisite of ligand-induced 
outside-in signaling. TM-clasping severely impaired outside-in signaling, leading to defects in 
cell spreading, migration, FA formation, and FAK activation. These defects could not be rescued 
by a whole αIIb cytoplasmic domain truncation. Our study also indicated that αIIb does not play an 
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important role in outside-in signaling. Removal of the entire αIIb cytoplasmic tail did not alter 
recruitment and activation of FAK and paxillin as well as actin polymerization. 
Materials and Methods 
Cell lines, Plasmid Construction, Expression, and Immunoprecipitation 
CHO-K1 cells were commercially purchased from ATCC (ATCC-CCL-61, Manassas, 
VA). Cells were maintained in MEM-α medium (Life Technologies, Grand Island, NY) 
supplemented with 10% FBS, 1% Non-Essential Amino Acids, 1% L-Glutamine, 1% Sodium 
Pyruvate and 1% Penicillin-Streptomycin (All from Life Technologies, Grand Island, NY). Wild 
type and truncated human integrin αIIb were cloned into pEF/V5-HisA; β3 was cloned into 
pcDNA3.1/Myc-His (+) [36]. Mutants were created by QuikChange kit (Stratagene, La Jolla, 
CA). Constructs were stably transfected into CHO-K1 cells using FuGENE transfection kit 
((Roche Diagnostics, Indianapolis, IN). The expression levels of αIIbβ3 were stained with the 
following monoclonal antibodies (mAbs): AP3 (anti-β3 mAb, American Type Culture 
Collection), 7E3 (anti-β3 mAb), and 10E5 (anti-αIIb mAb, gifted by B. S. Coller, Rockefeller 
University, NY) and evaluated by flow cytometry. To characterize disulfide bond formation, 
cells were labeled with 35S and lysed as described [20]. Lysates were immunoprecipitated with 
mAb 10E5 and protein G-Sepharose and subjected to SDS-PAGE and autoradiography.  
Soluble Ligand Binding Assay 
Soluble binding of the integrin ligand-mimetic IgM PAC-1 (BD Biosciences, San Jose, 
CA) and Alexa Fluor 488-labeled human fibrinogen (Enzyme Research Laboratories, South 
Bend, IN) was determined as previously described [44]. Cells suspended in 20 mM HEPES-
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buffered saline (pH 7.4) (HBS) supplemented with 5.5 mM glucose and 1% BSA were incubated 
on ice for 30 min with 10µg/mL PAC-1 or 20µg/mL labeled fibrinogen in the presence of either 
5mM EDTA, 5mM Ca2+, or 1mM Mn2+. Cells were also stained in parallel with 10E5. Binding 
activity is presented as the percentage of the mean fluorescence intensity (MFI) of PAC-1 or 
fibrinogen staining relative to the MFI of 10E5 staining. 
Cell spreading and Microscopy 
Glass-bottom six-well plates (MatTek Corporation, Ashland, MA) were coated with 20 
μg/mL fibrinogen in phosphate-buffered saline (PBS) at pH 7.4 overnight at 4°C and blocked 
with 1% BSA at room temperature for 1 h. The cells were detached with trypsin/EDTA and 
washed with serum-free DMEM containing 0.5mg/mL soybean trypsin inhibitor (EMD Millipore 
Corporation, Billerica, MA). Cells in suspension were incubated on ice for 30 minutes in DMEM 
containing 10 µg/mL mouse mAb LM609 before seeding on fibrinogen coated plates. The cells 
were seeded with or without 1 mM DTT and incubated at 37°C for 1 h.  Cells were then washed 
three times with PBS, fixed with formaldehyde, and subjected to differential interference contrast 
(DIC) imaging.  For confocal microscopy, cells were seeded in DMEM medium containing 
either blank DMSO, 1.5 µM/mL Wortmannin (Cell Signaling Technology, Danvers, MA), or 15 
µM/mL PP1 (EMD Millipore, Billerica, MA) for 1 h. After fixation, cells were permeabilized 
with 0.1% Triton X-100 and blocked with 1% BSA for 30 min. Phosphorylated FAK or paxillin 
were identified using rabbit polyclonal FAKpY397 antibody (Millipore, Billerica, MA) or rabbit 
paxillinpY31 polyclonal antibody (Life Technologies, Grand Island, NY), respectively. FA 
formation and actin filament organization were detected with Actin Cytoskeleton/Focal 
Adhesion Staining Kit (Millipore, Billerica, MA). Dylight 488 or dylight 633 conjugated 
secondary antibodies (Thermo Scientific Pierce, Rockford, IL) were used to stain primary 
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antibodies. Both DIC and confocal microscopy were conducted using a Leica TCS-SP2 spectral 
confocal system with a 63×/1.4 NA oil objective. Average cell areas were calculated from more 
than 100 randomly picked adherent cells and measured in pixels by ImageJ.  
Immunoblotting 
Cells were seeded onto 10cm petri dishes coated with 20 μg/mL fibrinogen or 1% BSA.  
After 1 h spreading at 37°C, adherent cells were washed three times with ice-cold PBS and lysed 
with TBS with 1% NP-40, 0.25% sodium deoxycholate, 1mM EDTA, 1mM Na3VO4, and 1mM 
NaF supplemented with protease, tyrosine phosphatase and serine/threonine phosphatase 
inhibitor cocktails (Sigma Aldrich, St. Louis, MO)]. Lysates were subjected to reducing SDS-
PAGE and transferred to PVDF membrane. The total amount of the kinases was determined by 
mouse monoclonal anti-FAK (BD Bioscience, San Jose, CA), rabbit monoclonal anti-Akt, or 
anti-Erk1/2 (Cell Signaling Technology Inc., Danvers, MA) antibody, respectively, and 
activation of the kinases was tested by rabbit monoclonal anti-FAKp397, anti-Aktp473, and anti-
Erk1/2p202/204 respectively (Cell Signaling Technology Inc., Danvers, MA). Mouse 
monoclonal GAPDH antibody (Sigma-Aldrich, St. Louis, MO) was used to determine total 
protein concentration. 
Wound-healing assay 
Six-well plates were pre-coated with 20 µg/mL fibrinogen followed by blocking with 1% 
BSA. Stable transfectants were then seeded in the wells, cultured to a confluent monolayer and 
serum starved overnight at 37°C. Artificial wounds were carefully created with sterilized 
micropipette tips. Cells were then washed twice with serum-free MEM-α medium and cultured 
in complete medium at 37°C. Closure of the artificial wounds was observed and recorded every 4 
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h for 12 h using the 10 × lens of an Olympus IX81 microscope. The wound closure rates were 




Expression of wild-type and mutated αIIbβ3 in CHO cells 
A previous study has shown that the double cysteine mutant αIIb_W968C and β3_I693C 
reversed inside-out activation and kept integrin in the low affinity state [20]. It has also been 
shown that the disulfide-bonded mutant abolished integrin outside-in signaling [43]. However, it 
is possible that the disulfide bridge constrained the cytoplasmic domains from separation, which 
might be a key factor in integrin bidirectional signaling. To dissect the role of the TM and 
cytoplasmic domains and further study the details of integrin bi-directional signaling, we 
introduced mutants that removed the αIIb cytoplasmic domain with or without the TM disulfide 
clasp. We established CHO cells stably transfected with each of the four different αIIbβ3 
constructs (Fig.4A): WT (B1), disulfide-bonded mutant (αIIb_W968C, β3_I693C; B2), truncated 
mutant (αIIb1-990; B3), and disulfide-bonded truncated mutant (αIIb1-990_W968C, β3_I693C; 
B4). Four cell lines were generated after single-cell sorting and the integrin αIIbβ3 expression 
levels were determined by staining with three specific mAbs: anti-β3 mAbs AP3 and 7E3, and an 
anti-αIIb mAb 10E5 (Fig.4B). Flow cytometry showed that the integrins from all three mutants 
were highly expressed and correctly folded, and the expression levels were comparable to each 




labeled proteins with the αIIb-specific mAb 10E5 (Fig.4C) confirmed that the efficiency of 
disulfide formation in the disulfide-bonded mutants (B2 and B4) was about 100%. These results 
indicated that clasping and truncating integrin αIIbβ3 did not affect overall protein folding; the 
high efficiency of disulfide formation made the cell lines ideal for studying the role of TM 






Figure 4: All αIIbβ3 mutants were successfully expressed with high disulfide-bridge formation 
efficiency. (A)Integrin αIIbβ3 constructs used in our study. B1: Wild type integrin αIIbβ3; B2: 
Disulfide-bonded αIIbβ3(αIIb_W968C, β3_I693C); B3: α truncated αIIbβ3(αIIb1-990); B4: α 
truncated, disulfide-bonded αIIbβ3 (αIIb1-990_W968C, β3_I693C). (B) Cell lines stably expressing 
WT and mutated integrin αIIbβ3 as evaluated by three different monoclonal antibodies. B1 (WT 
αIIbβ3), B2 (disulfide-bonded αIIbβ3 mutant), B3 (α-truncated αIIbβ3), and B4 (disulfide-bonded α-
truncated αIIbβ3). The solid line and dashed line represent untransfected CHO-K1 cells and stable 
transfectants, respectively. AP3, 7E3, and 10E5 are mAbs targeting different domains of the 
αIIbβ3 heterodimer. (C) Disulfide bonds formed between α and β subunits with high efficiency. 
Cells labeled with S35 were lysed and subjected to immunoprecipitation by anti-αIIb mAb 10E5. 
Immunoprecipitated protein was then resolved by SDS-PAGE and visualized by radioautography. 







TM domain separation is essential for high affinity αIIbβ3  
We determined the ability of the integrin αIIbβ3 mutants to bind ligands including PAC-1, 
a ligand mimetic mAb, and fibrinogen (Fig.5A and B). In the presence of Ca2+, both WT (B1) 
and the disulfide-bonded mutant (B2) showed similar low ligand binding, whereas the α-
truncated mutant (B3) exhibited much higher binding. However, the TM disulfide-bridge clasp 
of the mutant B4 reduced ligand binding to basal level. Reduction of the disulfide bond with 
DTT drastically increased ligand binding of the mutant. These results indicated that TM domain 
separation is required for the high affinity integrin that is induced by cytoplasmic domain 
dissociation.  
TM domain separation is indispensable for αIIbβ3-mediated outside-in signaling 
The binding of integrin to immobilized multivalent ligands can induce integrin clustering 
and outside-in signaling. To dissect the role of the TM and cytoplasmic domains in outside-in 
signaling, we used these integrin mutants to perform a cell spreading assay on immobilized 
fibrinogen (Fig.6). Clasping the TM domain abolished cell spreading (Fig.6, B2 and B4) 
regardless of the presence of the α subunit cytoplasmic domain. However, when the disulfide 
bond was reduced, cells spread similarly to the wild type cells (B1). The α-truncated mutant (B3) 
showed enhanced cell spreading compared to the WT, which may be caused by the higher ligand 
binding affinity of the mutant or by disruption of the α subunit-paxillin interaction, previously 

















































Confocal microscopy (Fig.7A and B) showed that both disulfide bonded mutants (B2 and 
B4) exhibited defective FA formation and actin filament organization. These defects were 
restored by DTT treatment, suggesting that cytoplasmic domain separation alone is insufficient 
for transmitting the outside-in signal. We further studied activation and recruitment of FAK to 
FAs (Fig.7C and D). We observed prominent recruitment of FAKpY397 to FAs (Fig.7C) in WT 
(B1) and the α truncated mutant (B3) but not in the TM-clasped mutants (B2 and B4). DTT 
treatment partially restored the recruitment (Fig.7D), suggesting that the TM domain separation 
is essential for outside-in signaling initiation and transduction.  
In the study, we also noticed that the B3 mutant showed more and larger focal adhesions 
(Fig.7E and F) and the FAs were distributed evenly at the edge of the cells (data not shown), 
suggesting loss of polarity during cell spreading. This result also implied that the mutant might 
be defective in directional cell migration; we observed defective cell migration in an in vitro 
wound healing assay (Fig.8). This phenomenon may be caused by lack of the α cytoplasmic tail, 
which was reported to inhibit cell spreading and promote cell migration in lymphocytes, or by 





























































Figure 7: TM domain separation is required for FA formation, actin fiber organization, FAK 
activation and recruitment to FA sites in outside-in signaling. (A) Clasping of TM domains 
ablated FA formation and disrupted actin filaments organization. Note that α truncation led to an 
even distribution of FAs around adherent cells. (B) Treatment with 1mM DTT largely restored 
cell spreading and FA assembly. Green: focal adhesions (labeled with anti-vinculin antibody); 
Red: actin filaments (labeled with TRITC-conjugated Phalloidin). White bar: 10µm. (C) 
Activated FAK (FAKpY397) was recruited normally to FAs in WT (B1) and the α-truncated 
mutant (B3), but recruitment was abolished by clasping the TM domains (B2 and B4). (D) 
Treatment with 1mM DTT restored recruitment of phosphorylated FAK to FAs. Green: 
FAKpY397; Red: actin filaments; Blue: FA marker vinculin. White bar: 10µm. (E, F) More and 
larger FAs were formed in the α-truncated mutant (B3) compared to the WT (B1). Error bars 




































































The role of the αIIb subunit cytoplasmic domain in outside-in signaling 
We reported earlier that FAK activation and recruitment were normal in both WT and the 
α truncated mutant (Fig.7C). Since the recruitment of activated FAK (FAKpY397) to FA sites is 
considered to be an early signature event of outside-in signaling [78], our observation implied 
that the αIIb cytoplasmic domain is dispensable in early stages of outside-in signaling. We then 
asked if the αIIb cytoplasmic domain is involved in a somehow later event, i.e. paxillin signaling. 
Phosphorylation of paxillin at tyrosines 31 and 118 was reported to be essential for lymphocyte 
migration [121,122]. If αIIb integrin is involved in paxillin signaling, deleting its cytoplasmic 
domain would result in both defective paxillin recruitment and reduced paxillin phosphorylation. 
We found that recruitment of phosphorylated paxillin (pY31) to FAs (Fig.9A) in both wild type 
(B1) and the α truncated mutant (B3) were similar, indicating that the αIIb integrin cytoplasmic 
tail is dispensable for paxillin recruitment and phosphorylation. Because both disulfide-bonded 
mutants (B2 and B4) exhibited defective phospho-paxillin recruitment, which was restored upon 
DTT treatment (Fig.9B), we concluded that TM domain separation is essential for FA signaling 
transduced through paxillin. We also determined the activation of Extracellular Signal-Regulated 
Kinase 1 and 2 (Erk1/2) during outside-in signaling because the MAPKs were reported to 
participate in paxillin-mediated signaling and cell survival [123,124]. We found that Erk1/2 
activity was significantly lower in the two disulfide-bonded mutants than in the WT and the α-
truncated mutant when adhering to immobilized Fbg (Fig.9C). This provided further evidence 
that TM domain separation but not the αIIb subunit is required for paxillin signaling and 
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bonded mutants, suggesting that the TM separation rather than αIIb cytoplasmic domain is 
essential in regulating FAK activity.  
The PI3K/Akt pathway has been reported to be involved in integrin-mediated signaling 
[115,116], and Akt specifically has been reported to be activated during outside-in signaling in 
platelets [125,126]. However, because this kinase is not directly related to small GTPases, which 
dictate cell spreading and migration, we hypothesized that the PI3K/Akt pathway might be 
dispensable for cell spreading but that the pathway may be required for MAPK activation to 
promote cell survival and proliferation. Indeed, we discovered that treatment with 1.5µM/mL of 
the PI3K inhibitor Wortmannin had little or no effect on cell spreading (Fig.11C and D), and 
both activated FAK and paxillin were recruited to FAs similarly to DMSO-treated cells (Fig.11A 
and B). Immunoblot results clearly showed that Akt activation was abolished by Wortmannin 
treatment (Fig.10B), whereas FAK activation was not affected by the treatment (Fig.10C). 
Erk1/2 activation was suppressed in cells treated with Wortmannin (Fig. 10B). Akt activation 
was dispensable for Erk1/2 activation because washing out of Wortmannin restored Erk1/2 
activation without enhancing Akt phosphorylation at S473 (Fig.10B). Taken together, the data 
strongly suggested that the PI3K/Akt pathway is not required for cell spreading and that PI3K 
but not Akt activity is required for cell survival and proliferation after attachment to the 































































































Activation of Src was reported to be required for Syk activation and essential for Syk-
mediated platelet spreading on fibrinogen [127,128]. However, we failed to observe any Src 
activation and recruitment of activated Src to FAs in any of our cell lines. We also tested whether 
the Src inhibitor PP1 could influence cell spreading. Cells treated with membrane permeable PP1 
(15 µM/mL) for 2 h prior to and during the cell spreading assay showed no observable difference 
in actin fiber arrangement, FAK/paxillin phosphorylation, or recruitment (Fig.11E and F). 
Similarly, treatment with another potent Src inhibitor, PP2 (15µM/mL), also did not affect 
outside-in signaling (Fig.12). Thus, Src activity-dependent outside-in signaling may be tissue 
specific and more prominent in hematopoietic cells than in other cells.  
Discussion 
Our study revealed for the first time that TM domain separation is an essential step 
downstream of cytoplasmic dissociation in integrin αIIbβ3 transmembrane signaling. Preventing 
the separation of the TM domain could abolish cytoplasmic tail dissociation induced high 
affinity integrin and immobilized ligand binding triggered outside-in signaling. The discovery 
strongly suggested that separation of the TM domain couples intracellular signaling cascades 
with extracellular conformational rearrangement and vice versa. Truncation of the α cytoplasmic 
tail did not induce high-affinity integrin in a TM-clasped mutant, indicating that dissociation of 
the TM domain takes place after cytoplasmic domain dissociation. Furthermore, instead of being 
an intermediate coupling step, TM separation is absolutely required for outside-in signaling and 
















Figure 11: Inhibition of PI3K and Src did not affect cell spreading, FAK/paxillin recruitment, or 
phosphorylation. (A, B) FAK and paxillin were phosphorylated and recruited to FAs normally in 
WT (B1) and the αIIb-truncated mutant (B3) with control treatment (DMSO). TM clasping 
abolished the events as previously observed; (C, D) Treatment with 1.5µM/mL Wortmannin did 
not affect recruitment of phosphorylated FAK and paxillin. (E, F) PP1 (15µM/mL) had little to 
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TM domain separation [129]. We have proposed that this process may be coupled with the 
following conformational changes of the integrin TM and cytoplasmic domains: (1) separation of 
two TM and cytoplasmic helices; (2) following separation, the α subunit helix maintains a 
similar structure, whereas the β TM domain may undergo a further conformational 
rearrangement by embedding five to six more residues into the lipid bilayer [13]. This hypothesis 
is supported by the boundary determination by glycosylation mapping in which monomeric β1 
TM domain was used [130]. In addition to the above mechanism, another possible way for 
integrin activation may come from force transmission from the actin cytoskeleton. It is possible 
that lateral force exerted on the β cytoplasmic domain by actin polymerization and contraction 
will pull the β-leg away from the α-leg and further stabilize opened headpiece with the swung-
out hybrid domain. The force can cause tilting on the membrane-embedded β TM domain in the 
plane of the membrane, stabilizing the dissociated helix in the membrane and facilitating force-
induced conformational change. We therefore proposed that this β TM domain rearrangement or 
tilting may be critical for integrin activation and signaling [13]. Mutation and disulfide-scanning 
studies revealed that TM-clasping can reverse high affinity αIIb GAAKR mutant, an inside-out 
activated integrin mimic, into the resting state [20]. This could be the result of either defective β 
TM helix rearrangement, i.e., separation and tilting, or spatial hindrance conferred by proximal 
αIIb cytoplasmic tail which may prevent binding of intracellular activators and building up of 
cytosol integrin activating stress force. Truncation of the entire αIIb cytoplasmic domain which 
eliminated any possible cytosol spatial impediment was unable to transmit inside-out activating 
signals in the TM-clasped integrin mutant. Therefore, our results implicated that β TM helix 
rearrangement is essential for integrin inside-out activation.  
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 Previous study showed that TM clasping abolishes outside-in signaling [43]. However, 
since a clasped TM domain likely leads to associated cytoplasmic domain which causes 
defective FA assembly, it is unclear if TM separation is essential for outside-in signaling or 
merely an intermediate step that leads to cytoplasmic dissociation. Our study clearly 
demonstrates that the TM separation itself is an essential conformational change in outside-in 
signaling. With the entire αIIb cytoplasmic tail removed, it is unlikely there is any spatial 
hindrance for kinases or other FA scaffold proteins to bind to the β3 cytoplasmic tail. Since TM-
clasping does not affect integrin clustering [43] and ligand binding affinity, it is most likely that 
the abolishment of cell spreading and FA assembly is caused by defective TM domain separation 
and β TM helix tilting instead of impaired α-β cytoplasmic domain dissociation. The separated 
and tilted β TM helix may be required for placing the β cytoplasmic domain into a position 
which favors assembly of the FA complex. It is probable that blocking TM separation by a 
disulfide-clasp can inhibit the tilted rearrangement of the β TM domain. However, further study 
is requried to prove this hypothesis. 
Studies of integrin signaling have largely focused on β integrin, thus the role of the α 
subunit cytoplasmic domain has remained elusive. It has also been reported that the α integrin 
cytoplasmic tail participates in outside-in signaling [125,131]. This mechanism, however, may 
not be required for initiation and transduction of integrin outside-in signaling, but rather could 
negatively affect cell spreading. In this study, we discovered that the αIIb integrin cytoplasmic tail 
is dispensable for cell spreading, FAK/paxillin phosphorylation and recruitment, and actin fiber 
organization, suggesting that β cytoplasmic tail alone is sufficient for transmitting outside-in 
signaling. However, more evenly distributed and larger (more mature) FAs in cells expressing α-
truncated integrin were also observed. The fact indicates that, though α integrin is not required 
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for cell interaction and spreading on ECM ligands, this subunit may be involved in FA turnover 
and directional cell migration. Our preliminary study suggests defective cell migration in α 
cytoplasmic domain truncation mutant. However, it is unclear if this phenomenon is caused by 
the mutation since a high ligand binding affinity induced by α-truncation may also lead to 
reduced cell motility. We are planning further studies to better understand these events.  
Kinases have long been considered important in integrin signaling. Akt activation in 
platelets during outside-in signaling has been reported [115,116]. However, there is no evidence 
that the PI3K/Akt pathway is related to the regulation of small GTPases, which has been shown 
to be essential for cell adhesion and spreading [114,132]. Therefore, we hypothesized a 
dispensable role for this pathway in outside-in signaling. Indeed, treatment with the PI3K-
specific inhibitor Wortmannin ablated Akt activation but did not affect cell spreading or 
FAK/paxillin phosphorylation and recruitment; Akt activation was not restored even after 
removal of Wortmannin. These results strongly suggested that Akt, though it may be activated in 
an integrin-dependent manner, does not play an important role in outside-in signaling. Activation 
of FAK and Src is thought to be the core part of the pathway [90,91]. However, neither 
introducing an unactivatable Src mutant [117] nor inhibition of FAK [118] ablated cell spreading. 
In addition, our study showed that Src inhibitors did not significantly affect FA formation and 
actin polymerization during outside-in signaling. This evidence implies that activation of the 
kinases may not be mandatory for firm adhesion and cell spreading. However, the kinases might 
play essential roles in further downstream signaling such as adhesion-dependent proliferation, 
directional migration, and tissue development. Further studies are needed to better understand the 







CHAPTER THREE: INTEGRIN αvβ8 ADOPTS A HIGH AFFINITY STATE 
UNDER PHYSIOLOGICAL CONDITIONS CAUSED BY THE β8 EGF1 
AND EGF2 INTERFACE. 
Introduction 
Integrins are α-β heterodimeric cell surface adhesive receptors that play an important role 
in many biological functions including cell migration, proliferation, differentiation and survival 
[133]. At least twenty-four integrins, which are composed of eighteen α and eight β subunits, 
have been identified in vertebrates [3]. Different integrin families with distinct subunit 
combinations have diverse functions due to submembrane linkers to cytoskeleton and 
intracellular proteins and different ligand-binding specificity and affinity. The αv integrins 
consist of five different families that play diverse roles in biology. One such family, integrin αvβ3 
has been widely reported as a key mediator in angiogenesis, adhesion, and migration [134]. It is 
also closely associated with tumor progression, invasion, and metastasis [135-137]. Notably, the 
expression level of αvβ3 is low in normal epithelial cells but dramatically higher in some 
malignant tumors. This up-regulation has been correlated with tumor progression [138]. Integrin 
αvβ8, however, is functionally distinct. For instance, αvβ8 is almost exclusively expressed in the 
central and peripheral nervous systems, and β8 integrin expression is correlated with central 
nervous system (CNS) development [139]. αvβ8 also regulates TGF-β1 activation and uniquely 
aids in the repair of neural cells, especially Schwann cells, by binding to ECM ligands and 
inducing growth, differentiation, and healing. The integrin is essential for embryonic 
development as β8 knock-out mice exhibited embryonic or perinatal lethality with abnormal 
vascular development [140,141]. Lack of interaction between latent TGF-β1 and αvβ8, which is 
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required for TGF-β1 activation, has been proposed to be the cause of these defects [142]. Despite 
interacting with vitronectin, the β8 integrin was reported as a non-adhesive receptor [143]. Later 
studies found that the cytoplasmic domain of the β8 integrin is completely different from other αv 
partners, including β1, β3, β5, and β6, which may explain why this integrin does not mediate cell 
adhesion like its siblings.  
Integrins are considered as special adhesion receptors because their adhesiveness can be 
dynamically regulated through a process termed inside-out signaling. On the cell surface, 
integrins normally adopt the low affinity state, and can be activated through the “inside-out” 
signaling pathway. Binding of the integrin extracellular ligands in turn transmits signals inward, 
a process called outside-in signaling, which exerts significant influences on cell mobility, 
proliferation and differentiation etc. [6]. It has been shown that many integrin families, including 
the β3 integrins, can transmit these bidirectional signals across the plasma membrane. However, 
the β8 cytoplasmic domain of the integrin lacks all the protein-protein interaction sites that have 
been identified on the β3 cytoplasmic domain and shows little homology to other αv pairing 
partners. This fact implicates that either the β8 integrin does not rely on inside-out signaling as 
other integrins or it uses a completely different set of machinery for cytosolic activation. 
Likewise, the integrin probably mediates a distinct outside-in signaling. 
It has been proposed that integrin bidirectional signaling is propagated through global 
conformational changes of the integrin extracellular domains termed as “switchblade” model 
[4,144]. According to this model, integrins exist on the cell surface as three different 
conformational states: bent, extended-closed and extended-open. In the crystal structures of the 
full length ectodomains of αvβ3 [7,145-147], αIIbβ3 [9] and αXβ2 [148], integrins are all in the bent 
conformation with the α- and β-subunit C-termini only a few angstroms apart, consistent with 
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association of the α- and β-subunit transmembrane domains. In this conformation, there is a 
highly acute bending between the α-subunit thigh and the calf-1 domains, as well as between the 
β-subunit epidermal growth factor domain 1 (EGF1) and the EGF2 domain. It was hypothesized 
that this bent conformation represents a resting, low affinity state, and inside-out activating 
signals induce separation of integrin TM/cytoplasmic domains followed by the separation of two 
ectodomain lower stalks, leading to the extension of these two legs [13,58,114]; integrin 
extension then results in the swing-out of the β-subunit hybrid domain, which causes the 
downward movement of the α7 helix of the β-I domain, leading to exposure of ligands binding 
site and high affinity for ligand binding [4]. In contrast, binding of ECM ligands triggers a 
piston- rod like movement of the β-I domain α7 helix downward and therefore forces the swing-
out motion of the hybrid domain. Due to the rigidity of the connections between the PSI and 
EGF1 domains and the hybrid domain, this motion can be propagated into a large scale extension 
and separation on the integrin legs [149]. In this hypothesis, the β3 ectodomain lower stalk plays 
a critical role on integrin bidirectional signaling. 
Even though this “switchblade” model has been supported by numerous experimental 
data, many questions remain unanswered. One basic question is whether the model universally 
applies to all the integrin families, i.e., does every integrin assume a bent conformation with low 
affinity for ligands under physiological conditions and go through this “switchblade”-like 
mechanism during integrin bidirectional signaling? Based on previous studies [150], we 
proposed that the β8 integrin might be an exception, which could adopt a conformation with high 
affinity for soluble ligands even at resting state. In this study, we expressed the αvβ8 integrin in 
HEK293T cells, and showed that this integrin bound soluble ligand much better than the β3 
integrin under physiological conditions. We then created chimeras containing the β3 ligand 
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binding head domain and different domains of β8 lower leg to verify our hypothesis and studied 
the ligand binding ability of these mutants. Our study indicated that the lower leg of the β8 
integrin is sufficient to convert the integrin chimera into a high ligand binding state. Further 
experiments revealed that swapping of the β8 EGF1-2 domains conferred integrin chimeras high 
affinity towards soluble ligand to a level similar to the whole lower leg swapping, implicating 
that these two EGF subdomains play a key role in high ligand binding affinity. Our study showed 
that the β8 integrin EGF 1-2 domains, especially the joint interface between the two domains, 
play a critical role in stabilizing integrin αvβ8 in the high affinity conformation. 
Material and Methods 
Cell lines, Plasmid Construction and Expression 
HEK293T cells (American Type Culture Collection, Manassas, VA) were maintained in DMEM 
medium (Life Technologies, Grand Island, NY) supplemented with 10% FBS, 1% Non-Essential 
Amino Acids, 1% L-Glutamine, 1% Sodium Pyruvate and 1% Penicillin-Streptomycin (all from 
Life Technologies, Grand Island, NY). Plasmids containing wild type human integrin αv and β3 
were described previously [8]. Wild type β8 integrin was generously gifted by Dr. Nishimura 
[143]. All of the chimera constructs were created via overlap PCR and the mutants were created 
by QuikChange kit (Stratagene, La Jolla, CA). Constructs were transiently transfected into 
HEK293T cells using X-tremegene 9 transfection kit ((Roche Diagnostics, Indianapolis, IN). The 
expression levels of the wild type integrins, the chimeras and the mutants were determined by 
flow cytometry staining with monoclonal antibody AP3 (anti-β3 mAb, American Type Culture 
Collection), MAb1980 (anti-αv mAb, EMD Millipore Corporation, Billerica, MA) and 37E1 





Soluble Ligand Binding Assay 
Soluble binding of Alexa Fluor 488-labeled human vitronectin and fibronectin (both from 
Sigma-Aldrich, St. Louis, MO) was determined as previously described [44]. Briefly, transfected 
cells suspended in 20 mM HEPES-buffered saline (pH 7.4) (HBS) supplemented with 5.5 mM 
glucose and 1% BSA were pre-blocked with 1 µg anti-β1 antibody (EMD Millipore Corporation, 
Billerica, MA) on ice for 30 min and then coated with 20 µg/mL labeled vitronectin or 
fibronectin at room temperature in the presence of either 5 mM EDTA, 5 mM Ca2+, or 1 mM 
Mn2+. For vitronectin binding, cells were then stained with MAb1980 on ice for 30 min and 
labeled with dylight 633 conjugated anti-mouse IgG antibody (Thermo Scientific Pierce, 
Rockford, IL). For fibronectin binding, cells were incubated with Alexa Fluor 543-labeled AP3 
on ice for 30 min. Binding activity was presented as the percentage of the mean fluorescence 
intensity (MFI) of ligands staining relative to the MFI of MAb1980 or AP3 staining. 
Cell adhesion assay 
96-well plates (BD Biosciences, San Jose, CA) were coated with 1 μg/well fibrinogen in 
phosphate-buffered saline (PBS) at pH 7.4 overnight at 4°C and blocked with 1% BSA at room 
temperature for 2 hrs. The cells were detached with trypsin/EDTA and washed with serum-free 
DMEM containing 0.5mg/mL soybean trypsin inhibitor (EMD Millipore Corporation, Billerica, 
MA). Cells in suspension were incubated on ice for 30 minutes in DMEM containing 1 µg anti-
β1 antibody before seeding on fibrinogen coated wells. After 45 min incubation, the cells were 
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then washed three times with ice cold PBS. Adherent cells were lysed by 1% Triton X-100 and 
quantified by LDH detection kit (Clontech Laboratories, Mountain View, CA). 
 
Cell spreading and Microscopy 
Glass-bottom six-well plates (MatTek Corporation, Ashland, MA) were coated with 20 
μg/mL fibrinogen in phosphate-buffered saline (PBS) at pH 7.4 overnight at 4°C and blocked 
with 1% BSA at room temperature for 2 hrs. The cells were detached with trypsin/EDTA and 
washed with serum-free DMEM containing 0.5mg/mL soybean trypsin inhibitor. Cells in 
suspension were incubated on ice for 30 minutes in DMEM containing 1 µg anti-β1 antibody 
before been seeded on fibrinogen coated plates. The cells were seeded and incubated at 37°C for 
45 min.  Cells were then washed three times with PBS, fixed with formaldehyde, and subjected 
to differential interference contrast (DIC) imaging.  For confocal microscopy, cells were 
permeabilized with 0.1% Triton X-100 and blocked with 1% BSA for 30 min. Phosphorylated 
FAK and integrin constructs were identified using rabbit polyclonal FAKpY397 antibody 
(Millipore, Billerica, MA) or AP3, respectively. FA formation and actin filament organization 
were detected with Actin Cytoskeleton/Focal Adhesion Staining Kit (Millipore, Billerica, MA). 
Dylight 488- or dylight 633-conjugated secondary antibodies (Thermo Scientific Pierce, 
Rockford, IL) were used to stain primary antibodies.  
Both DIC and confocal microscopy were conducted using a Leica TCS-SP2 spectral 
confocal system with a 63×/1.4 NA oil objective. Average cell areas were calculated from more 







Expression and soluble vitronectin binding of integrin αvβ8 on the cell surface 
 It has been proposed that integrins normally assume a bent conformation with low 
affinity for ligands on the cell surface whereas extracellular stimuli activate integrin from cytosol 
and induce extension with high affinity towards ligands [4,5,13,114,151]. However, based on the 
fact that there is no binding site in the β8 cytoplasmic domain for inside-out activators, we 
propose that αvβ8 integrin may adopt a different conformation with high affinity to its ligands 
under physiological conditions. To verify this hypothesis, we first expressed integrins αvβ3 and 
αvβ8 in the 293T cells, and used antibody staining to confirm their expression on the cell surface. 
As shown in Figure 1A, αv-specific MAb1980 bound both transfectants well. The anti-β3 mAb 
AP3 bound 293T cells expressing αvβ3 only, but not αvβ8 and control cells, confirming previous 
observation that there is no endogenous αvβ3 expression in 293T cells. By contrast, the anti-β8 
mAb 37E1 bound cells transfected with αvβ8, indicating efficient expression and proper folding 
of the integrin on the cell surface (Fig. 13A).  
To determine the ligand binding capacity, soluble ligand binding assay was performed 
using recombinant human vitronectin labeled with Alexa-488 (Fig. 13B). As expected, αvβ3 
bound little soluble vitronectin in the presence of 5mM Ca2+, whereas the presence of Mn2+ 
increased vitronectin binding significantly. By contrast, integrin αvβ8 bound soluble vitronectin 
in the presence of Ca2+ with the maximal level, even better than that of αvβ3 in Mn
2+. Addition of 
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The lower leg of β8 renders integrin high affinity for ligands 
We further designed experiments to verify which domain(s) play a key role in converting 
integrin β8 into higher affinity for ligands under physiological conditions. Integrin αvβ3 has been 
widely studied in integrin bidirectional signaling; therefore, we constructed β3β8 chimeras with 
the whole β3 lower leg and/or TM- cytoplasmic domains swapped with the corresponding β8 
domains (Fig. 14A). We then performed soluble ligand binding assay to test ligand binding 
ability of the chimeras (Fig. 14B). We used human fibronectin labeled with Alexa-488 instead of 
vitronectin because fibronectin is more affordable, well studied, and more importantly, unlike 
vitronectin as shown in Figure 1, the basal binding of integrin αvβ3 to soluble fibronectin is very 
low under the physiological Ca2+ condition. Therefore, fibronectin is more sensitive to identify 
the change of the ligand binding ability. As expected, the wild-type αvβ3 bound soluble 
fibronectin poorly in the presence of Ca2+, whereas addition of Mn2+ significantly increased the 
binding capability. By contrast, the chimera containing the whole β8 lower leg (β3β8Leg) bound 
soluble fibronectin in the presence of Ca2+, comparable to the wild-type αvβ3 in Mn
2+ (Fig. 14B). 
We also used soluble fibrinogen binding assay to determine the ligand binding ability of the 
chimera, and similar results were obtained (data not shown). These experiments suggested that 
the β8 leg is important for the physiological high affinity towards soluble ligands expressed by 
































Figure 14: β3β8 chimera carrying β8 exofacial lower stalk showed high ligand binding. A. β3β8 
chimeras were created by swapping different β8 domains but not the ligand binding head domain 
with corresponding β3 domains. β3β8Leg: β3 head domain with β8 exofacial lower stalk (EGF 
domains and βTD domain) and β8 TM-Cytoplasmic domain. β3β8EGF-βTD: β3 integrin carrying 
a β8 exofacial lower stalk. β3β8TMCyt: intact β3 integrin ectodomain with β8 TM-Cytoplasmic 
domain. B. Binding of Alexa A488 labelled fibronectin to HEK293T cells that were transiently 
transfected with W.T. β3 or different β3β8 chimeras in the presence of either EDTA (5mM); Ca
2+ 
(5mM) or Mn2+ (1mM) as indicated. The β3β8Leg chimera expressed much higher ligand 
binding affinity by comparing to W.T. and β3β8TMCyt. Error bars represent standard deviation 








We then constructed the chimera with the β8 TM and cytoplasmic domains (β3β8TM-
Cyt). The chimera showed moderately increased binding to soluble fibronectin and the addition 
of Mn2+ could further enhance the ligand binding, as observed in wild-type αvβ3. The results 
suggested that unlike any other integrins such as αvβ3 and αIIbβ3, which are in the bent 
conformation with low affinity for ligands under the physiological conditions and assume a 
conformational change upon inside-out signaling, the αvβ8 is unique in exhibiting a high affinity 
for ligands without necessity of inside-out activation. The β8 lower exofacial stalk, which is 
composed of four EGF domains, is critical for its high ligand binding affinity. The β8 EGF 
domains may play a key role on integrin conformational regulation and ligand binding affinity.  
 
The EGF1 and EGF2 domains render the β8 integrin high affinity for ligand binding  
On the lower leg of integrins there are four integrin EGF like domains (I-EGF1-4), which 
consist of multiple cysteine residues forming three or four disulfide bridges on each domain. It 
has been shown that these domains are critical in integrin affinity regulation [9,152]. We 
therefore continued our study to identify which of these domains contribute to the higher ligand 
binding of the β3β8 chimera. The soluble ligand binding assay indicated that the chimera carrying 
the β8 ectodomain lower stalk (β3β8EGF-βTD), which comprises the four I-EGF domains and 
the βTD domain, bound fibronectin similar to the chimera β3β8Leg in the presence of Ca2+ (Fig. 
15A). The result further confirmed that exofacial lower stalk is the major contributor to high 
affinity integrin. Moreover, our experiment showed that swapping of the β3 EGF1-2 domains 
with those of the β8 increased ligand binding ability to a level similar to that of the β3β8EGF-
βTD and β3β8Leg chimeras (Fig. 15A). In contrast, swapping of the β3 EGF1 domain alone only 
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moderately increased fibronectin binding. Our results suggested that integrin β8 assumes a 
conformation with higher ligand binding affinity mainly because of the β8 EGF1 and 2 domains. 
We aligned the sequences of β8 EGF domains with those of β3 integrin (Fig. 15B), and 
found significant differences within the EGF1 domain. One prominent difference was that the β8 
EGF1 domain contains only the first two disulfide bridges whereas the β3 integrin carries a third 
one at the C-terminal of the subdomain. Previous reports showed that mutations of several 
cysteine residues of the EGF domains lead to activation of integrin αIIbβ3 or αvβ3 [153,154]. We 
therefore extended the study to pinpoint if the high affinity state expressed by the chimeras was 
caused by the different pattern of disulfide bridging between β3 and β8 EGF domains. We created 
β3 alanine mutants of either cysteine that forms the third disulfide bridge to test if the missing 
disulfide bridge is important in maintaining low affinity conformation. The alanine mutation 
moderately reduced the expression or folding of αvβ3 on the cell surface (data not shown). Then 
soluble fibronectin binding was tested and our results showed that mutating either one of the 
cysteines greatly increased ligand binding ability (Fig. 15C). Specifically, the C462A mutation 
bound soluble fibronectin to a comparable level as the chimera β3β8EGF1 whereas the mutant 
















Figure 15: β8 EGF1 and EGF2 domains on exofacial lower stalk is sufficient for high affinity 
state. A. Binding of Alexa A488 labelled fibronectin to HEK293T cells that were transiently 
transfected with different β3β8 chimeras in the presence of either EDTA (5mM); Ca
2+ (5mM) or 
Mn2+ (1mM) as indicated. The chimera containing β8 exofacial lower stalk but not TM and 
cytoplasmic domains expressed similar affinity as the β3β8Leg chimera. The β3β8EGF1 chimera 
showed moderate affinity which can be further increased by swapping in β8 EGF2 domain 
(β3β8EGF1&2). B. Sequence alignments of I-EGF1-4 domains between β3 and β8 integrin. Bold 
character: residues with similar biochemical properties; Bold character with underline: same 
residue; grey characters: non-homologous residues; lines: disulfide bridges. C. Soluble ligand 
binding assay was used to test the effect of two cysteine to alanine mutants (C462A and C471A) 
on β3 binding affinity. Both mutants showed enhanced ligand binding whereas mutant C471A 
expressed higher affinity than C462A, which is possibly caused by the proximity of the residue 
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EGF1 or EGF 1-2 subdomains did not affect cell adhesion at all (Fig. 16A). Two cysteine 
mutants exhibited moderately reduced cell adhesion, and this reduction was probably due to 
relatively lower expression efficiency of the mutant integrins as identified by flow cytometry 
(data not shown).  
The binding of integrins to immobilized multivalent ligands can induce integrin 
clustering and outside-in signaling. To dissect the role of different β8 domains in outside-in 
signaling, we first used these chimeras to perform cell spreading assay on immobilized 
fibrinogen (Fig. 16B & C). As expected, the wild-type αvβ3 could spread well on the coated 
surface. By contrast, the chimeras that carry the β8 cytoplasmic domain showed severe defects in 
overall morphology and spreading area (the β3β8Leg in Fig. 16B & C). All other chimeras that 
carry different domains on β8 exofacial lower stalk could spread as well as the wild-type αvβ3, 
suggesting that even though the β8 EGF domains play an important role in integrin global 
conformational change and ligand-binding affinity, they have no negative effects on cell 
morphogenesis during integrin mediated outside-in signaling. 
 Integrin clustering induced by multimeric ligand-binding results in formation of short-
lived, transient nascent cell-ECM contacts which will either be dissembled or mature into more 
stable focal adhesions later [155-157]. During this process, the recruitment of focal adhesion 
kinase (FAK) to the integrin cytoplasmic domain has been reported to be an early event in 
outside-in signaling [78,79]. We therefore tested the ability of the chimeras to induce FAK 
activation and recruitment (Fig. 17). After adhering to immobilized fibrinogen, cells expressing 
the wild-type αvβ3 showed significant spreading with formation of stable focal adhesion. The 
activated FAK (as indicated by phosphorylation of Y397), actin and integrins were co-localized 











Figure 16: β8 exofacial lower stalk did not negatively affect cell adhesion and spreading. A. 
HEK293T cells were transiently transfected with constructs as indicated and blocked with anti-β1 
antibody (4µg/mL) before been seeded on flat bottom 96-well plates pre-coated with 1µg/well 
fibrinogen (Fbg). Adherent cells were quantified via LDH assay and normalized to total input 
cells. Error bars represent S.D. from at least three independent assays. B. Cells transiently 
transfected with constructs as above were seeded on immobilized Fbg (20µg/mL) for 30min at 
37°C and visualized using differential interference contrast (DIC). Images are representatives 
from one of three independent assays. White bar: 10µm. C. Average areas of adherent cells were 
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By contrast, cells expressing the chimera swapped with the full β8 leg showed abolished 
focal adhesion formation upon adhesion, and no co-localization of the activated FAK, actin and 
integrin could be observed. The chimeras carrying all or part of the β8 EGF domains and the 
cysteine mutant expressed normal cell spreading and FAK activation/recruitment (Fig. 17). Our 
results showed clearly that the integrin cytoplasmic domain, but not any of the EGF domains, 
plays a key role on integrin outside-in signaling. The β8 integrin is defective in integrin outside-




 Two β3 integrins (αIIbβ3 and αvβ3) have been widely studied as models for integrin 
bidirectional signaling. On the contrary, little is known about the β8 family, which also associates 
with αv integrin and belongs to RGD receptor family. Its affinity and conformational states still 
remain elusive. In this study, we showed that integrin β8 assumes a high affinity state under 
physiological conditions. By using chimeras that combined the ligand binding head domain of 
the β3 integrin with different domains of the β8 integrin leg, we dissected many important 
features of the β8 integrin. Our study showed that the high ligand binding of integrin αvβ8 is 
mainly due to the β8 EGF domains 1-2. In addition, we verified that the defective outside-in 
signaling observed in αvβ8 integrin is probably due to the lack of protein-binding sites on the β8 
cytoplasmic domain, but not the EGF domains on the ectodomain. 
 It has been shown that many integrin families adopt a bent conformation with low affinity 
towards ligands in a resting state and can be converted into extended, high affinity conformation 
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upon inside-out activation [5,144]. However, it is unclear whether such a “switchblade”-like 
conformational change is mandatory for every integrin family upon inside-out activation or 
binding to ECM ligands in order to perform proper functions. Our study showed that the β8 
integrin is likely an exception. This integrin lacks all the identified binding sites of integrin 
cytosol activators, indicating that the integrin is unable to be activated from cytosol. In this study, 
our experiments showed that the β8 integrin expressed high affinity towards soluble ligands even 
under physiological conditions. Therefore, this integrin family may not necessarily go through an 
intracellular signal-induced conformational change to switch into a high affinity state and 
become functional. This is the first integrin family that has been shown to exist in an active state 
under physiological conditions. The discovery has many important implications for the 
mechanism of the integrin conformational signaling as well as the relationship between the 
integrin signal transduction and diverse biological functions. 
Our study showed that the β8 integrin adopts a high affinity state mainly due to the EGF 
1-2 domains. The β integrin lower leg contains four EGF domains that are cysteine-rich. Each of 
the last three EGF domains (EGF 2-4) normally contains eight cysteines residues forming four 
disulfide-bridges, whereas the first EGF domain (EGF1) normally has three pairs with the 
exception of the β8 integrin, which contains only two pairs of cysteines (Fig. 18A) [9,147]. The 
lower β leg bends sharply between EGF1 and EGF2 domain forming a β knee which is extended 
and straightened during integrin activation [9]. Because of the importance of the EGF domains in 
integrin conformational regulation, we predicted that if the β8 integrin assumes a constitutively 
high affinity state, the β8 EGF domains, especially the EGF 1-2, may be important in stabilizing 
this high affinity conformation. Indeed, when we swapped the lower leg of β3 integrin with that 
of the β8, the chimera expressed hyper affinity towards soluble ligands. We further discovered 
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that swapping of both EGF1-2 domains achieved similar activity as the whole β8 lower leg, 
whereas swapping of only the β8 EGF1 domain alone is sufficient to convert β3β8 chimera into 
high affinity state, but not as high as that of both domains. Our results showed that the β8 integrin 
assumes high affinity because of the interface between the EGF1 and EGF2 domains on its lower 
leg.  
When we compared the sequence of the β8 lower leg with that of the β3, we found the 
major differences are located within the EGF1 domain. The β8 EGF1 not only lacks the third 
disulfide bond, but lacks the whole loop of the β3 integrin between the two cysteines that form 
the third disulfide bridge (Fig. 15B).  Actually, the β8 integrin is unique among all β subunits 
because it lacks this whole loop (Fig. 18A). Our experiments showed that mutating either 
cysteine residue increased soluble ligand binding (Fig. 14). In addition, deleting the whole or 
part of (G465WLG) the loop increased soluble ligand binding, but deletion mutants had lower 
expression efficiency on the cell surface (data not shown). In the crystal structure of αIIbβ3 [9] 
and αvβ3 [146], this loop is located at the interface between the EGF1 and 2 domains (Fig. 18B). 
Since mutating or deleting this β3 loop not only increased ligand binding, but also decreased 
integrin expression, this loop may contribute to the stability of the bent, low affinity 
conformation and protein folding. We therefore propose that the β8 EGF1-2 domains may 
assume a different conformation rather than the bent one. It is possible that the interface between 
the EGF1 and EGF2 domains stabilizes this integrin in the extended conformation, similar to the 
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 The β8 integrin has previously been reported as a vitronectin receptor that does not 
support cell adhesion and spreading [143]. However, the defective outside-in signaling of β8 
integrin can be caused by either the β8 ectodomain or its cytoplasmic domain, which lacks 
binding sites for cytoskeleton proteins, or by both. Our research clearly indicated that the lower 
stalk of the β8 integrin, comprised by the EGF and βTD domains, does not significantly affect 
cell adhesion, spreading and FAK activation/recruitment. The cysteine mutations on β3 integrin 
EGF1 domain did not cause any observable defect in outside-in signaling either.    
 In conclusion, our research revealed for the first time that the β8 integrin probably adopts 
a constitutively high affinity state under physiological conditions. We showed that the high 
affinity structure is mainly due to the β8 lower leg and specifically, the EGF1 and EGF2 domains. 
This conformational state is likely crucial for β8 integrin functions. One of the most important 
biological roles of the β8 integrin is mediating maturation and activation of TGF-β1, which is 
achieved through binding to latent TGF-β1 and introducing MT1-MMP dependent active TGF-
β1 release [150]. Since the β8 cytoplasmic tail lacks binding sites for all the known integrin 
cytosol activators, it is most likely that the only way for this integrin to efficiently bind latent 
TGF-β1 is maintaining high affinity state under physiological conditions. However, more 
research is required to confirm if the high affinity conformation is indispensable for β8 to 








CHAPTER FOUR: GENERAL DISCUSSION AND CONCLUSION 
Because of the important role in hemostasis, cell proliferation and differentiation and 
tissue development, integrins have been intensively studied during past decades and significant 
progress has been made in integrin structure and bidirectional signaling. However, many details 
regarding the integrin transmembrane signaling and the ectodomain structural regulation remain 
elusive. 
We have shown in Chapter two that the TM domain separation is an essential step 
downstream of the cytoplasmic dissociation in integrin αIIbβ3 transmembrane signaling. Both 
integrin inside-out activation and outside-in signaling were abolished completely by TM domain 
clasping. Large scale conformational change is likely required for activating signals to transmit 
through ~200 Å distance from the cytoplasmic tail to the integrin head domain, leading to 
conformational change of the ligand binding site. Our discovery indicated that the separation of 
the TM domain couples the cytoplasmic domain separation with the extension of the integrin 
legs, making the swing-out of the hybrid domain and the piston-like movement of the βI-α7 helix 
possible. During outside-in signaling, binding of ECM ligands triggers downward movement of 
the βI-α7 helix followed by the hybrid domain swing-out and leg separation. In the process, it is 
possible that TM domain dissociation merely functions as a “bridging” step that connects the 
cytoplasmic domain dissociation with the leg separation, and thus this TM dissociation can be 
bypassed by the αIIb cytoplasmic tail truncation.  However, our studies showed that the TM-
clasped mutant containing a deleted αIIb cytoplasmic tail was defective in outside-in signaling, 
suggesting  that the TM domain conformational rearrangement is required for assembly of the 
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FA complex on the β cytoplasmic domain.  This discovery established the TM domain as an 
indispensable step in outside-in signaling. In addition, our study also showed that the αIIb 
cytoplasmic tail does not play a major role in the signal transduction pathway since the αIIb 
cytoplasmic tail truncation mutant mediated outside-in signaling normally. The subunit might be 
involved in cell migration but further study is required to obtain a better understanding of its role 
in integrin signaling. 
We also studied the role of kinases in integrin mediated outside-in signaling. Akt 
activation was previously observed in platelets during outside-in signaling [115,116]. However, 
our results suggested that this kinase does not play an essential role in outside-in signaling. 
Furthermore, we observed normal cell spreading in the presence of high concentration of Src 
inhibitors and in another preliminary study, cells expressing a chimera in which the TM domain 
of the β3 integrin is replaced by the β8 TM domain showed normal cell spreading but defective 
FAK activation and recruitment.  The evidence suggests that the kinases may be dispensable for 
firm adhesion formation and cell spreading. However, since phosphorylation on integrin and 
many scaffold proteins is critical for focal adhesion turnover and cell migration [85,158], kinases 
may play essential roles in cell mobility. 
 Affinity regulation is essential for proper biological functions for integrins and the 
conformational rearrangement of the integrin extracellular domain is essential for the process. It 
has been generally accepted that the extracellular conformational change upon cytoplasmic 
activation or ECM ligand binding follows a “switchblade” like mechanism [4,5,149]. This model 
proposes that integrins switch between three conformational states: the bent-closed, the 
extended-closed and the extended-open conformations, which correspond to the low, 
intermediate and high affinity states, respectively. Integrins normally adopt the bent-closed 
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conformation with low affinity towards ligands under physiological conditions; whereas, inside-
out activating signal dissociates the α and β subunit TM and cytoplasmic domains [13,58,114]. 
This conformational change can be propagated outward, leading to large scale separation of the α 
and β legs and integrin extension. As a result, the conformational rearrangement is directed 
towards the ligand-binding headpiece, leading to downward movement of the α7 helix on the βI 
domain. The α7 helix functions as a crankshaft and its downward movement can induce exposure 
of the ligand binding interface as well as stabilizing extended legs [149]. Similarly, engagement 
of mutivalent ECM ligands also triggers downward motion of the βI domain α7 helix, which is 
followed by separation of the lower legs and the cytoplasmic domains, making integrin ready for 
outside-in signaling transduction.  
The switchblade model has been well supported by experimental evidence. However, it is 
important to verify if the model fits all integrins.  Our study in Chapter 3 showed that the β8 
family, which associates with the αv subunit and belongs to RGD receptor family, assumes a high 
affinity state under physiological conditions. The β8 integrin cytoplasmic domain does not 
contain any known binding sites for integrin cytoplasmic activators, suggesting the integrin may 
not be able to be activated from cytosol. Therefore, it may not be necessary for this integrin 
family to go through an intracellular signal induced conformational change to switch into a high 
affinity state in order to become functional. Our discovery makes integrin β8 the first identified 
integrin family that assumes high affinity state without presence of extracellular stimuli. 
Furthermore, our observation indicated that instead of changing of conformations among three 
different states some integrins such as β8 may assume only one conformation to be functional. 
Since the bent, low affinity conformation has been widely regarded as a “resting” state of 
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integrin under physiological conditions [5,159], finding an integrin with high affinity at resting 
state is particularly important.  
Our study further revealed that the high affinity state of β8 integrin is mainly due to the 
EGF 1-2 domains. The missing C-terminal cysteine pair and the whole loop on the β8 EGF1 
domain might stabilize this integrin in a state other than the bent conformation that most of the 
other integrins such β3 adopt. In the bent conformation, an acute bending between the EGF1 and 
the EGF2 domains is observed, which is considered as a hallmark of the low affinity state 
[7,9,145-148]. The bending forms a β knee which is extended and straightened during integrin 
activation [9]. Therefore, it is very likely that β3 EGF1 C-terminal loop favors an overall bent 
conformation under physiological conditions by stabilizing EGF1-EGF2 interface, whereas 
absence of the loop on the β8 EGF1 favors the extended conformation.  
The β8 integrin shows severe defects in outside-in signaling, which can be caused by 
either the β8 ectodomain or the cytoplasmic domain or both. In Chapter three we also verified 
that the defective outside-in signaling observed in integrin αvβ8 is probably due to absence of 
protein-binding sites on the β8 cytoplasmic domain, but not the EGF domains on the ectodomain. 
Considering the importance of conformational regulation in integrin signaling and function, 
future studies of the β8 integrin could lead to many important discoveries for the mechanism of 
the integrin conformational signaling as well as the relationship between the integrin signal 
transduction and diverse biological functions. 
Future direction: 
 We are currently conducting research to dissect different roles of the TM domain in 
different integrins. The β8 integrin TM domain probably does not play a significant role in its 
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conformational regulation and signaling. In contrast, the β3 integrin affinity state is closely 
related to its TM domain conformation. By studying the differences of TM domain regulation 
between the β integrin families sharing the same α subunit (αvβ3 and αvβ8) and between integrins 
composed of the same β subunits but with different α subunits (αvβ3 and αIIbβ3), we may obtain a 
better understanding of the TM regulation in integrin signaling and conformational change, as 
well as their diverse biological functions. Outside-in signaling of the β8 integrin remains elusive. 
Our preliminary research indicated that the defective cell adhesion and spreading of the β8 
integrin are not caused by absence of cytoskeleton or kinase recruiting sites but instead by an 
unidentified signal pathway, which contradicts with the known integrin outside-in signaling. The 
chimera bearing the fused β3β8 cytoplasmic domain expressed defective cell spreading, which 
can be rescued by partial β8 cytoplasmic domain truncations. We will continue our study in this 
topic to achieve a better understanding of the β8 integrin mediated outside-in signaling.   
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